We also demonstrated that miR-141 agomir inhibits HNSCC metastasis in vivo and that miR-141 also inhibits expression of EGFR, CDK4, bcl-2 and MMP2 in vivo. This evidence concerns the gene BCL2 and head and neck squamous cell carcinoma.